HER3-DXd
U31402-A-U103
Phase 1 small_molecule active
Quick answer
HER3-DXd for Non-Small Cell Lung Cancer (NSCLC) is a Phase 1 program (small_molecule) at Daiichi Sankyo with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo
- Indication
- Non-Small Cell Lung Cancer (NSCLC)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active